USC‐087 protects Syrian hamsters against lethal challenge with human species C adenoviruses

[1]  W. Wold,et al.  Male Syrian hamsters are more susceptible to intravenous infection with species C human adenoviruses than are females. , 2018, Virology.

[2]  J. Kurtzberg,et al.  Brincidofovir for Asymptomatic Adenovirus Viremia in Pediatric and Adult Allogeneic Hematopoietic Cell Transplant Recipients: A Randomized Placebo-Controlled Phase II Trial. , 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[3]  J. Sagartz,et al.  Pathology in Permissive Syrian Hamsters after Infection with Species C Human Adenovirus (HAdV-C) Is the Result of Virus Replication: HAdV-C6 Replicates More and Causes More Pathology than HAdV-C5 , 2017, Journal of Virology.

[4]  Hyun Woong Park,et al.  Treatment of Adenoviral Acute Respiratory Distress Syndrome Using Cidofovir With Extracorporeal Membrane Oxygenation , 2017, Journal of intensive care medicine.

[5]  Eun Jung Lee,et al.  Clinical Features and Courses of Adenovirus Pneumonia in Healthy Young Adults during an Outbreak among Korean Military Personnel , 2017, PloS one.

[6]  A. Karimi,et al.  Anti-adenovirus activity, antioxidant potential, and phenolic content of black tea (Camellia sinensis Kuntze) extract , 2016, Journal of complementary & integrative medicine.

[7]  P. Stoilov,et al.  Suppression of Adenovirus Replication by Cardiotonic Steroids , 2016, Journal of Virology.

[8]  S. Pinkert,et al.  Biological Antivirals for Treatment of Adenovirus Infections , 2016, Antiviral therapy.

[9]  Peng Zhan,et al.  First discovery of novel 3-hydroxy-quinazoline-2,4(1H,3H)-diones as specific anti-vaccinia and adenovirus agents via ‘privileged scaffold’ refining approach , 2016, Bioorganic & Medicinal Chemistry Letters.

[10]  J. Albano,et al.  Safety evaluation of adenovirus type 4 and type 7 vaccine live, oral in military recruits. , 2016, Vaccine.

[11]  Hui Li,et al.  Sustained Viremia and High Viral Load in Respiratory Tract Secretions Are Predictors for Death in Immunocompetent Adults with Adenovirus Pneumonia , 2016, PloS one.

[12]  R. O'reilly,et al.  Virus-specific T-cell banks for 'off the shelf' adoptive therapy of refractory infections , 2016, Bone Marrow Transplantation.

[13]  Huadong Zhu,et al.  Severe Community-Acquired Pneumonia Caused by Human Adenovirus in Immunocompetent Adults: A Multicenter Case Series , 2016, PloS one.

[14]  K. Carroll,et al.  Diagnostic Microbiology of the Immunocompromised Host, Second Edition , 2016 .

[15]  J. Sánchez-Céspedes,et al.  Antiadenovirus drug discovery: potential targets and evaluation methodologies. , 2015, Drug discovery today.

[16]  R. Aurora,et al.  Transcriptome sequencing and development of an expression microarray platform for liver infection in adenovirus type 5-infected Syrian golden hamsters , 2015, Virology.

[17]  H. Fechner,et al.  Enhanced suppression of adenovirus replication by triple combination of anti-adenoviral siRNAs, soluble adenovirus receptor trap sCAR-Fc and cidofovir. , 2015, Antiviral research.

[18]  O. Povnitsa,et al.  Synthesis and Comparative Study of Anti-Adenoviral Activity of 6-Azacytidine and Its Analogues , 2015, Nucleosides, nucleotides & nucleic acids.

[19]  Se Jin Kim,et al.  Outcomes of Early Administration of Cidofovir in Non-Immunocompromised Patients with Severe Adenovirus Pneumonia , 2015, PloS one.

[20]  H. Einsele,et al.  Adoptive T-cell therapy with hexon-specific Th1 cells as a treatment of refractory adenovirus infection after HSCT. , 2015, Blood.

[21]  J. Sagartz,et al.  Valganciclovir Inhibits Human Adenovirus Replication and Pathology in Permissive Immunosuppressed Female and Male Syrian Hamsters , 2015, Viruses.

[22]  M. Mohamed,et al.  Novel Antiviral Compounds against Gastroenteric Viral Infections , 2015, Archiv der Pharmazie.

[23]  K. Korn,et al.  A Novel CDK7 Inhibitor of the Pyrazolotriazine Class Exerts Broad-Spectrum Antiviral Activity at Nanomolar Concentrations , 2015, Antimicrobial Agents and Chemotherapy.

[24]  R. Buller,et al.  Cidofovir and brincidofovir reduce the pathology caused by systemic infection with human type 5 adenovirus in immunosuppressed Syrian hamsters, while ribavirin is largely ineffective in this model. , 2014, Antiviral research.

[25]  R. Buller,et al.  Ganciclovir Inhibits Human Adenovirus Replication and Pathogenicity in Permissive Immunosuppressed Syrian Hamsters , 2014, Antimicrobial Agents and Chemotherapy.

[26]  D. Florescu,et al.  Development of CMX001 (Brincidofovir) for the treatment of serious diseases or conditions caused by dsDNA viruses , 2014, Expert review of anti-infective therapy.

[27]  T. Lion.  Adenovirus Infections in Immunocompetent and Immunocompromised Patients , 2014, Clinical Microbiology Reviews.

[28]  U. Sandkovsky,et al.  Adenovirus: Current Epidemiology and Emerging Approaches to Prevention and Treatment , 2014, Current Infectious Disease Reports.

[29]  R. Khanna,et al.  Cellular immune therapy for viral infections in transplant patients , 2013, The Indian journal of medical research.

[30]  T. Lion,et al.  Diagnosis and treatment of adenovirus infection in immunocompromised patients , 2013, Expert review of anti-infective therapy.

[31]  Winnie Ip,et al.  22q11.2 deletion syndrome with life-threatening adenovirus infection. , 2013, The Journal of pediatrics.

[32]  H. Field,et al.  Recent developments in anti-herpesvirus drugs. , 2013, British medical bulletin.

[33]  N. Peet,et al.  Synthesis and Antiviral Activities of Methylenecyclopropane Analogs with 6-Alkoxy and 6-Alkylthio Substitutions That Exhibit Broad-Spectrum Antiviral Activity against Human Herpesviruses , 2013, Antimicrobial Agents and Chemotherapy.

[34]  Xinwen Chen,et al.  Dioscin's antiviral effect in vitro. , 2013, Virus research.

[35]  W. M. El-Senousy,et al.  Synthesis and antiviral evalution of some novel pyrazoles and pyrazolo[3,4-d]pyridazines bearing 5,6,7,8-tetrahydronaphthalene. , 2013, Acta poloniae pharmaceutica.

[36]  T. Lion,et al.  Inhibition of adenovirus multiplication by short interfering RNAs directly or indirectly targeting the viral DNA replication machinery , 2012, Antiviral research.

[37]  W. Wold,et al.  Chapter three--Syrian hamster as an animal model to study oncolytic adenoviruses and to evaluate the efficacy of antiviral compounds. , 2012, Advances in cancer research.

[38]  E. Kern,et al.  The search for new therapies for human cytomegalovirus infections. , 2011, Virus research.

[39]  R. DeBiasi,et al.  Eradication of disseminated adenovirus infection in a pediatric hematopoietic stem cell transplantation recipient using the novel antiviral agent CMX001. , 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[40]  A. Leen,et al.  How I treat adenovirus in hematopoietic stem cell transplant recipients. , 2010, Blood.

[41]  G. Painter,et al.  Development of CMX001 for the Treatment of Poxvirus Infections , 2010, Viruses.

[42]  K. Hostetler.  Synthesis and Early Development of Hexadecyloxypropylcidofovir: An Oral Antipoxvirus Nucleoside Phosphonate , 2010, Viruses.

[43]  T. Lion,et al.  Monitoring of adenovirus load in stool by real-time PCR permits early detection of impending invasive infection in patients after allogeneic stem cell transplantation , 2008, Leukemia.

[44]  K. Hostetler.  Alkoxyalkyl prodrugs of acyclic nucleoside phosphonates enhance oral antiviral activity and reduce toxicity: current state of the art. , 2009, Antiviral research.

[45]  E. De Clercq,et al.  Clinical features and treatment of adenovirus infections , 2008, Reviews in medical virology.

[46]  J. Sagartz,et al.  Hexadecyloxypropyl-cidofovir, CMX001, prevents adenovirus-induced mortality in a permissive, immunosuppressed animal model , 2008, Proceedings of the National Academy of Sciences.

[47]  W. Wold,et al.  Preparation and titration of CsCl-banded adenovirus stocks. , 2007, Methods in molecular medicine.

[48]  M. Ison.  Adenovirus Infections in Transplant Recipients , 2006 .

[49]  Kortney M. Gustin,et al.  Ether lipid-ester prodrugs of acyclic nucleoside phosphonates: activity against adenovirus replication in vitro. , 2005, The Journal of infectious diseases.

[50]  S. Dupuis-Girod,et al.  In Vitro Susceptibility of Adenovirus to Antiviral Drugs is Species-Dependent , 2005, Antiviral therapy.

[51]  A. Holý.  Phosphonomethoxyalkyl analogs of nucleotides. , 2003, Current pharmaceutical design.

[52]  G. Painter,et al.  Esterification of cidofovir with alkoxyalkanols increases oral bioavailability and diminishes drug accumulation in kidney. , 2003, Antiviral research.

[53]  K. Cundy.  Clinical Pharmacokinetics of the Antiviral Nucleotide Analogues Cidofovir and Adefovir , 1999, Clinical pharmacokinetics.

[54]  S. Eriksson,et al.  Substrate specificity of human recombinant mitochondrial deoxyguanosine kinase with cytostatic and antiviral purine and pyrimidine analogs. , 1998, Molecular pharmacology.

[55]  B. Kuppermann,et al.  Intravenous Cidofovir for Peripheral Cytomegalovirus Retinitis in Patients with AIDS , 1997, Annals of Internal Medicine.

[56]  A. Holý,et al.  Synthesis of isomeric and enantiomeric O-phosphonylmethyl derivatives of 9-(2,3-dihydroxypropyl)adenine , 1987 .

[57]  I. Rosenberg,et al.  Stereospecific syntheses of 9-(S)-(3-hydroxy-2-phosphonylmethoxypropyl)adenine (HPMPA). , 1987, Nucleic acids symposium series.